UBS Group Downgrades DiaSorin (OTCMKTS:DSRLF) to Hold

DiaSorin (OTCMKTS:DSRLF) was downgraded by investment analysts at UBS Group from a “strong-buy” rating to a “hold” rating in a research note issued to investors on Tuesday,Zacks.com reports.

DiaSorin Stock Performance

OTCMKTS:DSRLF opened at $107.88 on Tuesday. The firm has a 50-day simple moving average of $103.07 and a two-hundred day simple moving average of $103.07. DiaSorin has a fifty-two week low of $107.88 and a fifty-two week high of $107.88.

DiaSorin Company Profile

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.